Commission Implementing Regulation (EU) No 118/2012 of 10 February 2012 amending Regulations (EC) No 2380/2001, (EC) No 1289/2004, (EC) No 1455/2004, (EC) No 1800/2004, (EC) No 600/2005, (EU) No 874/2010, Implementing Regulations (EU) No 388/2011, (EU) No 532/2011 and (EU) No 900/2011 as regards the name of the holder of the authorisation of certain additives in animal feed and correcting Implementing Regulation (EU) No 532/2011 Text with EEA relevance

Amendment to Regulation (EC) No 2380/2001

Article 1

In column 2 of the Annex to Regulation (EC) No 2380/2001, the words ‘Alpharma Belgium BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Regulation (EC) No 1289/2004

Article 2

In column 2 of the Annex to Regulation (EC) No 1289/2004, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Regulation (EC) No 1455/2004

Article 3

In column 2 of the Annex to Regulation (EC) No 1455/2004, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Regulation (EC) No 1800/2004

Article 4

In column 2 of the Annex to Regulation (EC) No 1800/2004, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Regulation (EC) No 600/2005

Article 5

In column 2 of Annex I to Regulation (EC) No 600/2005, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Regulation (EU) No 874/2010

Article 6

In column 2 of the Annex to Regulation (EU) No 874/2010, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Implementing Regulation (EU) No 388/2011

Article 7

In column 2 of the Annex to Implementing Regulation (EU) No 388/2011, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Implementing Regulation (EU) No 532/2011

Article 8

In column 2 of Annex I to Implementing Regulation (EU) No 532/2011 the words ‘Alpharma Belgium BVBA’ are replaced by ‘Pfizer Ltd’.

Amendment to Implementing Regulation (EU) No 900/2011

Article 9

In column 2 of the Annex to Implementing Regulation (EU) No 900/2011, the words ‘Alpharma (Belgium) BVBA’ are replaced by ‘Pfizer Ltd’.

Correction to Implementing Regulation (EU) No 532/2011

Article 10

Annex II to Implementing Regulation (EU) No 532/2011 is corrected in accordance with the Annex to this Regulation.

Transitional measures

Article 11

Existing stocks which are in conformity with the provisions applying before the date of entry into force of this Regulation may continue to be placed on the market and used until 2 September 2012.

Entry into force

Article 12

This Regulation shall enter into force on the 20th day following its publication in the Official Journal of the European Union . Article 10 and the Annex shall, however, apply from 21 June 2011.

ANNEXSupplementary provisions

ANNEX In Annex II to Implementing Regulation (EU) No 532/2011, the Annex to Regulation (EC) No 1800/2004 as amended by Implementing Regulation (EU) No 532/2011 is corrected as follows: (1) in column 3 the words ‘(Cycostat 66G)’ are replaced by ‘(Robenz 66 G)’; (2) A new column is added: ‘Maximum residue limits (MRLs) in the relevant foodstuffs of animal origin 800 μg robenidine hydrochloride/kg of wet liver. 350 μg robenidine hydrochloride/kg of wet kidney. 200 μg robenidine hydrochloride/kg of wet muscle. 1 300 μg robenidine hydrochloride/kg of wet skin/fat. 400 μg robenidine hydrochloride/kg of skin/fat. 400 μg robenidine hydrochloride/kg of wet liver. 200 μg robenidine hydrochloride/kg of wet kidney. 200 μg robenidine hydrochloride/kg of wet muscle.’